Williams
WMB
71.46
-0.93
-1.28%
Williams
US · WMB
#248 by market cap
Listed 1970
71.46
-0.93
-1.28%
Live - 5344 symbols - heartbeat 44s ago
· 2026-10-08 06:12
Pre-market
70.54
-1.29%
After-hours
71.46
0.00%
Overnight
71.47
+0.01%
- Market cap
- 87.41B
- P/E (TTM)i
- 28.47
- P/Bi
- 6.64
- EPSi
- 2.14
- Div yieldi
- 2.87%
- 52W posi
- 69%
Reader sentiment
Are you bullish or bearish on WMB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.30, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +13.78% YoY
Margins
- Gross margin
- 61.96%
- Operating margin
- 36.89%
- Net margin
- 21.88%
Key ratios & quality
- Enterprise valuei
- 116.74B
- PEG ratioi
- 3.34
- Altman Z-Scorei
- 1.30
PEG uses trailing P/E against the 3-year net income growth rate (8.51%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.69B | 8.20B | 7.72B | 10.63B | 10.97B | 10.91B | 10.50B | 11.95B |
| Gross profit | 4.12B | 4.42B | 4.39B | 4.75B | 5.50B | 6.80B | 6.17B | 7.40B |
| Selling & admin expenses | 569.00M | 558.00M | 466.00M | 558.00M | 636.00M | 665.00M | 708.00M | 721.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.99B | 2.39B | 2.57B | 2.63B | 3.02B | 4.19B | 3.34B | 4.41B |
| Pretax profit | 331.00M | 1.06B | 277.00M | 2.07B | 2.54B | 4.41B | 2.99B | 3.63B |
| Tax | 138.00M | 335.00M | 79.00M | 511.00M | 425.00M | 1.01B | 640.00M | 857.00M |
| Net profit | 193.00M | 714.00M | 198.00M | 1.56B | 2.12B | 3.30B | 2.35B | 2.77B |
| Basic EPS | 0 | 1 | 0 | 1 | 2 | 3 | 2 | 2 |
| Diluted EPS | -0.16 | 0.70 | 0.17 | 1.24 | 1.67 | 2.60 | 1.82 | 2.14 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.05B | 2.78B | 2.92B | 3.20B | 3.03B | 3.05B |
| Gross profit | 1.82B | 1.70B | 1.87B | 2.01B | 1.89B | 1.95B |
| Selling & admin expenses | 194.00M | 168.00M | 168.00M | 191.00M | 193.00M | 180.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.09B | 945.00M | 1.11B | 1.26B | 1.14B | 1.17B |
| Pretax profit | 922.00M | 757.00M | 929.00M | 1.02B | 1.16B | 1.14B |
| Tax | 193.00M | 174.00M | 246.00M | 244.00M | 244.00M | 260.00M |
| Net profit | 729.00M | 583.00M | 683.00M | 773.00M | 912.00M | 876.00M |
| Basic EPS | 1 | 0 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.56 | 0.45 | 0.53 | 0.60 | 0.70 | 0.68 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.46B | 1.58B | 1.43B | 4.55B | 3.80B | 4.51B | 2.66B | 3.24B |
| Cash & ST investments | 168.00M | 289.00M | 142.00M | 1.68B | 152.00M | 2.15B | 60.00M | 63.00M |
| Inventory | 130.00M | 125.00M | 136.00M | 379.00M | 320.00M | 274.00M | 279.00M | 314.00M |
| Total assets | 45.30B | 46.04B | 44.17B | 47.61B | 48.43B | 52.63B | 54.53B | 58.57B |
| Total current liabilities | 1.81B | 3.97B | 2.32B | 4.97B | 4.89B | 5.83B | 5.31B | 6.11B |
| Short-term debt | 47.00M | 2.16B | 921.00M | 2.05B | 1.00B | 3.09B | 2.20B | 2.08B |
| Long-term debt | 22.37B | 20.15B | 21.45B | 21.65B | 21.93B | 23.38B | 24.74B | 27.32B |
| Total liabilities | 29,305,000,000.00 | 29,676,000,000.00 | 29,582,000,000.00 | 33,511,000,000.00 | 34,388,000,000.00 | 37,736,000,000.00 | 39,692,000,000.00 | 43,578,000,000.00 |
| Total equity | 16.00B | 16.36B | 14.58B | 14.10B | 14.05B | 14.89B | 14.84B | 15.00B |
| Retained earnings | -10.00B | -11.00B | -12.75B | -13.24B | -13.27B | -12.29B | -12.40B | -12.24B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.54B | 3.22B | 2.27B | 3.24B | 3.32B | 3.12B |
| Cash & ST investments | 100.00M | 903.00M | 70.00M | 63.00M | 950.00M | 203.00M |
| Inventory | 249.00M | 335.00M | 339.00M | 314.00M | 262.00M | 335.00M |
| Total assets | 54.92B | 56.14B | 55.74B | 58.57B | 59.57B | 60.61B |
| Total current liabilities | 6.27B | 6.01B | 5.38B | 6.11B | 4.01B | 6.55B |
| Short-term debt | 3.29B | 2.97B | 2.40B | 2.08B | 248.00M | 2.67B |
| Long-term debt | 24.12B | 25.60B | 25.59B | 27.32B | 30.05B | 28.12B |
| Total liabilities | 40,059,000,000.00 | 41,336,000,000.00 | 40,876,000,000.00 | 43,578,000,000.00 | 44,407,000,000.00 | 45,242,000,000.00 |
| Total equity | 14.87B | 14.81B | 14.86B | 15.00B | 15.16B | 15.37B |
| Retained earnings | -12.32B | -12.39B | -12.35B | -12.24B | -12.02B | -11.83B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.29B | 3.69B | 3.50B | 3.95B | 4.89B | 5.94B | 4.97B | 5.90B |
| Depreciation & amortization | 1.73B | 1.71B | 1.72B | 1.84B | 2.01B | 2.07B | 2.22B | 2.35B |
| Free cash flow | 30.00M | 1.54B | 2.22B | 2.70B | 2.61B | 3.37B | 2.30B | 899.00M |
| Dividends paid | -1.39B | -1.84B | -1.94B | -1.99B | -2.07B | -2.18B | -2.32B | -2.44B |
| Stock buybacks / issuance | 15.00M | 10.00M | 9.00M | 9.00M | 45.00M | -124.00M | 10.00M | 9.00M |
| Ending cash balance | 168.00M | 289.00M | 142.00M | 1.68B | 152.00M | 2.15B | 60.00M | 63.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.43B | 1.45B | 1.44B | 1.58B | 1.60B | 1.38B |
| Depreciation & amortization | 585.00M | 605.00M | 564.00M | 593.00M | 584.00M | 592.00M |
| Free cash flow | 421.00M | 438.00M | 445.00M | -405.00M | 244.00M | -458.00M |
| Dividends paid | -610.00M | -611.00M | -611.00M | -610.00M | -642.00M | -642.00M |
| Stock buybacks / issuance | 5.00M | 0 | 4.00M | 0 | 8.00M | 0 |
| Ending cash balance | 100.00M | 903.00M | 70.00M | 63.00M | 950.00M | 203.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -1.29 | 6.06 | 1.66 | 13.10 | 17.92 | 26.67 | 17.94 | 20.78 |
| ROA %i | -0.34 | 1.85 | 0.46 | 3.30 | 4.26 | 6.29 | 4.15 | 4.62 |
| ROIC %i | 1.94 | 4.57 | 3.00 | 6.94 | 8.64 | 11.12 | 8.29 | 9.04 |
| 5-year avg ROE %i | 8.92 | 3.93 | 5.80 | 9.99 | 7.49 | 13.08 | 15.46 | 19.28 |
| EBIT margin %i | 16.61 | 27.44 | 18.77 | 30.60 | 33.64 | 51.72 | 41.42 | 42.40 |
| FCF / sales %i | 0.35 | 18.83 | 28.77 | 25.39 | 23.77 | 30.91 | 21.86 | 7.52 |
| Current ratioi | 0.81 | 0.40 | 0.62 | 0.91 | 0.78 | 0.77 | 0.50 | 0.53 |
| Quick ratioi | 0.64 | 0.32 | 0.49 | 0.64 | 0.41 | 0.60 | 0.31 | 0.28 |
| Debt / assetsi | 49.48 | 48.46 | 50.66 | 49.77 | 47.34 | 50.28 | 49.40 | 50.18 |
| LT debt / equityi | 152.94 | 151.17 | 182.81 | 190.11 | 191.50 | 189.02 | 199.47 | 213.87 |
| Interest coveragei | 1.30 | 1.90 | 1.24 | 2.76 | 3.22 | 4.56 | 3.19 | 3.51 |
| Revenue CAGR (3Y) %i | 5.68 | 3.03 | -1.31 | 6.95 | 10.17 | 12.21 | -0.39 | 2.91 |
| Net income CAGR (3Y) %i | -- | -- | -54.04 | -- | 34.08 | 146.98 | 13.62 | 8.51 |
| FCF CAGR (3Y) %i | -- | -9.80 | 50.70 | 348.03 | 19.06 | 14.92 | -5.24 | -29.87 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 18.35 | 19.67 | 19.03 | 20.78 | 21.95 | 24.02 |
| ROA %i | 4.24 | 4.47 | 4.32 | 4.62 | 4.87 | 5.26 |
| ROIC %i | 8.49 | 8.83 | 8.67 | 9.04 | 9.41 | 9.92 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 40.97 | 41.25 | 40.23 | 42.40 | 44.65 | 46.94 |
| FCF / sales %i | 18.80 | 15.96 | 14.98 | 7.52 | 6.05 | -- |
| Current ratioi | 0.40 | 0.54 | 0.42 | 0.53 | 0.83 | 0.48 |
| Quick ratioi | 0.24 | 0.38 | 0.25 | 0.28 | 0.62 | 0.31 |
| Debt / assetsi | 49.91 | 50.89 | 50.21 | 50.18 | 50.87 | 50.81 |
| LT debt / equityi | 193.72 | 206.43 | 204.96 | 213.87 | 231.95 | 213.77 |
| Interest coveragei | 3.24 | 3.37 | 3.28 | 3.51 | 3.63 | 3.84 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Product sales is the largest reported line at 39.93% of revenue, across 7 reported segments.
- No single line clears half of revenue; Monetary consideration is next at 37.73%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Product sales39.93%
Monetary consideration37.73%
Regulated interstate natural gas transportation and storage30.30%
Other revenues18.93%
Commodity consideration1.47%
Other1.24%
Quote time 2026-10-08 06:12:59 · For reference only, not investment advice and not tailored to your situation.